Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate.
Add Yahoo as a preferred source to see more of our stories on Google. Cancer remains one of humanity's most formidable challenges, claiming the lives of millions every year despite decades of medical ...
A phase 3 trial found that adding chemoradiotherapy (CRT) after induction chemotherapy in patients with unresectable pancreatic cancer did not extend overall survival compared to chemotherapy alone ...
The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News ...
After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical ...
Millions of Americans take daily supplements—including nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide (NAM)—to ...
Cancer remains one of humanity’s most formidable challenges, claiming the lives of millions every year despite decades of medical progress. While some cancers respond well to treatment when diagnosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results